Knights Of Columbus Asset Advisors LLC Amicus Therapeutics, Inc. Transaction History
Knights Of Columbus Asset Advisors LLC
- $1.59 Billion
- Q2 2025
A detailed history of Knights Of Columbus Asset Advisors LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Knights Of Columbus Asset Advisors LLC holds 5,842 shares of FOLD stock, worth $40,485. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,842
Previous 5,842
-0.0%
Holding current value
$40,485
Previous $47,000
29.79%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding FOLD
# of Institutions
305Shares Held
321MCall Options Held
378KPut Options Held
575K-
Wellington Management Group LLP Boston, MA29.2MShares$202 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.1MShares$201 Million0.0% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$169 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY21.5MShares$149 Million7.33% of portfolio
-
Avoro Capital Advisors LLC New York, NY20.5MShares$142 Million2.71% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $1.94B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...